137 related articles for article (PubMed ID: 3190191)
21. Concentrations of erythromycin in serum and tonsil: comparison of the estolate and ethyl succinate suspensions.
Ginsburg CM; McCracken GH; Culbertson MC
J Pediatr; 1976 Dec; 89(6):1011-3. PubMed ID: 792404
[TBL] [Abstract][Full Text] [Related]
22. Effect of erythromycin on the oro-caecal transit time in man.
Lehtola J; Jauhonen P; Kesäniemi A; Wikberg R; Gordin A
Eur J Clin Pharmacol; 1990; 39(6):555-8. PubMed ID: 2095341
[TBL] [Abstract][Full Text] [Related]
23. Concentrations of cefpodoxime in plasma, adenoid, and tonsillar tissue after repeated administrations of cefpodoxime proxetil in children.
Bairamis TN; Nikolopoulos TP; Kafetzis DA; Begue P; Lenfant B; Kandiloros DC; Apostolopoulos NJ
J Antimicrob Chemother; 1996 Apr; 37(4):821-4. PubMed ID: 8722549
[TBL] [Abstract][Full Text] [Related]
24. [Pharmacodynamics of erythromycin lactobionate during tonsillectomy in children].
Leuthardt R; Trümpi B; Morger R
Schweiz Med Wochenschr; 1989 Oct; 119(40):1372-4. PubMed ID: 2799345
[TBL] [Abstract][Full Text] [Related]
25. [Comparative study of doxycycline and erythromycin concentrations in the palatine tonsils].
Miniti A; Butugan O; Paiva LJ
Rev Hosp Clin Fac Med Sao Paulo; 1970; 25(6):371-8. PubMed ID: 5496438
[No Abstract] [Full Text] [Related]
26. Selection of dose regimens of azithromycin .
Foulds G; Johnson RB
J Antimicrob Chemother; 1993 Jun; 31 Suppl E():39-50. PubMed ID: 8396095
[TBL] [Abstract][Full Text] [Related]
27. Plasma levels following single and repeated doses of erythromycin estolate and erythromycin stearate.
Welling PG; Elliott RL; Pitterle ME; Corrick-West HP; Lyons LL
J Pharm Sci; 1979 Feb; 68(2):150-5. PubMed ID: 423080
[TBL] [Abstract][Full Text] [Related]
28. Comparative pharmacology of josamycin and erythromycin stearate.
Strausbaugh LJ; Bolton WK; Dilworth JA; Guerrant RL; Sande MA
Antimicrob Agents Chemother; 1976 Sep; 10(3):450-6. PubMed ID: 984786
[TBL] [Abstract][Full Text] [Related]
29. Penetration of cefprozil into tonsillar and adenoidal tissues.
Shyu WC; Reilly J; Campbell DA; Wilber RB; Barbhaiya RH
Antimicrob Agents Chemother; 1993 May; 37(5):1180-3. PubMed ID: 8517711
[TBL] [Abstract][Full Text] [Related]
30. Concentrations of cloxacillin and erythromycin in the tonsils of children after administration of therapeutic doses.
Brzezińska H; Brózik H; Mikucki J; Sobiś M; Szarapińska J
Int J Pediatr Otorhinolaryngol; 1984 Mar; 7(1):51-61. PubMed ID: 6724810
[TBL] [Abstract][Full Text] [Related]
31. The diffusion of clarithromycin and roxithromycin into nasal mucosa, tonsil and lung in humans.
Fraschini F; Scaglione F; Pintucci G; Maccarinelli G; Dugnani S; Demartini G
J Antimicrob Chemother; 1991 Feb; 27 Suppl A():61-5. PubMed ID: 1827103
[TBL] [Abstract][Full Text] [Related]
32. Absorption of erythromycin acistrate and erythromycin base in the fasting and non-fasting state.
Tuominen RK; Männistö PT; Pohto P; Solkinen A; Vuorela A
J Antimicrob Chemother; 1988 Jun; 21 Suppl D():45-55. PubMed ID: 3391875
[TBL] [Abstract][Full Text] [Related]
33. Plasma and saliva concentrations for a new formulation of erythromycin stearate.
Berend N; Rutland J; Marlin GE
Curr Med Res Opin; 1979; 6(2):118-23. PubMed ID: 467089
[TBL] [Abstract][Full Text] [Related]
34. Penetration of penicillin V to tonsillar surface fluid in healthy individuals and in patients with acute tonsillitis.
Stjernquist-Desatnik A; Samuelsson P; Walder M
J Laryngol Otol; 1993 Apr; 107(4):309-12. PubMed ID: 8320515
[TBL] [Abstract][Full Text] [Related]
35. Plasma and tonsillar tissue pharmacokinetics of teicoplanin following intramuscular administration to children.
Aarons L; Rowland M; Khan A; Taborelli G; Ferrea G; Tarantino V; Fioredda F; Rosina-Parenti R; Cavenaghi L; Borgonovi M
Eur J Pharm Sci; 1998 Oct; 6(4):265-70. PubMed ID: 9795079
[TBL] [Abstract][Full Text] [Related]
36. Miocamycin distribution in tonsillar and pulmonary tissues after repeated administration.
Scaglione F; Falchi M; Nebuloni R; Cattaneo G; Pintucci JP; Mezzetti M; Zampella K; Saudelli M; Casini A; Fraschini F
J Chemother; 1990 Dec; 2(6):384-9. PubMed ID: 2093111
[TBL] [Abstract][Full Text] [Related]
37. The bioavailability of erythromycin stearate versus enteric-coated erythromycin base when taken immediately before and after food.
Clayton D; Leslie A
J Int Med Res; 1981; 9(6):470-7. PubMed ID: 7319133
[TBL] [Abstract][Full Text] [Related]
38. Improved tonsillar disposition of azithromycin following a 3-day oral treatment with 20 mg kg(-1) in paediatric patients.
Baschiera F; Fornai M; Lazzeri G; Blandizzi C; Bruschini P; del Tacca M
Pharmacol Res; 2002 Jul; 46(1):95-100. PubMed ID: 12208127
[TBL] [Abstract][Full Text] [Related]
39. Treatment of respiratory tract infections with erythromycin acistrate and two formulations of erythromycin base.
Wuolijoki E; Flygare U; Hildén M; Hurme J; Järvinen H; Leskinen J; Pynnönen S; Riikonen A; Salomaa V; Seuri M
J Antimicrob Chemother; 1988 Jun; 21 Suppl D():107-12. PubMed ID: 3391872
[TBL] [Abstract][Full Text] [Related]
40. Concentration of moxifloxacin in plasma and tonsillar tissue after multiple administration in adult patients.
Esposito S; Noviello S; D'Errico G; Motta G; Passali D; Aimoni C; Pilucchi S; Fallani S; Cassetta MI; Mazzei T; Novelli A
J Antimicrob Chemother; 2006 Apr; 57(4):789-92. PubMed ID: 16504997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
